Cite
HARVARD Citation
Weiler, K. et al. (n.d.). P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy. Journal for immunotherapy of cancer. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Weiler, K. et al. (n.d.). P18. The tumour leukocyte infiltrate is the key predictor for therapeutic response to catumaxomab therapy. Journal for immunotherapy of cancer. p. . [Online].